Robert W. Baird restated their hold rating on shares of R1 RCM (NASDAQ:RCM) in a research note released on Monday morning. The brokerage currently has a $7.00 price objective on the financial services provider’s stock.
Other equities research analysts have also issued reports about the stock. BidaskClub raised shares of R1 RCM from a buy rating to a strong-buy rating in a report on Wednesday, December 27th. Zacks Investment Research lowered shares of R1 RCM from a hold rating to a sell rating in a report on Wednesday, January 17th.
R1 RCM (NASDAQ RCM) opened at $6.56 on Monday. The stock has a market capitalization of $647.85, a price-to-earnings ratio of -25.23 and a beta of -0.41. R1 RCM has a 12-month low of $2.12 and a 12-month high of $6.75.
COPYRIGHT VIOLATION WARNING: “R1 RCM (RCM) Earns Hold Rating from Robert W. Baird” was reported by Ticker Report and is the sole property of of Ticker Report. If you are viewing this story on another site, it was copied illegally and reposted in violation of U.S. and international trademark & copyright laws. The legal version of this story can be read at https://www.tickerreport.com/banking-finance/3229828/r1-rcm-rcm-earns-hold-rating-from-robert-w-baird.html.
R1 RCM Company Profile
R1 RCM Inc is a provider of revenue cycle management (RCM) and physician advisory services (PAS) to healthcare providers. The Company is engaged in providing management services of revenue cycle operations for the United States-based hospitals and other medical services providers. Its primary service offering consists of end-to-end RCM, which the Company deploys through a co-managed relationship or an operating partner relationship.
Receive News & Ratings for R1 RCM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for R1 RCM and related companies with MarketBeat.com's FREE daily email newsletter.